Aravive Inc (DELISTED) (ARAV:DL)
0.0401
0.00 (0.00%)
USD |
NASDAQ |
Feb 07, 16:00
Price Chart
Key Stats
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | -- |
Profile
| Aravive Inc is a clinical-stage biopharmaceutical company. It focuses on developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis. The company pipeline product Batiraxcept (formerly AVB-500) which is an ultra-high affinity decoy protein that binds to GAS6 and thereby prevents AXL signaling to inhibit metastasis and tumor growth and restore sensitivity to anti-cancer agents. Batiraxcept is currently being evaluated in multiple clinical trials. |
| URL | https://www.aravive.com |
| Investor Relations URL | http://ir.versartis.com/ |
| HQ State/Province | Texas |
| Sector | |
| Industry | |
| Equity Style | Small Cap/Value |
| Next Earnings Release | Mar. 15, 2024 (est.) |
| Last Earnings Release | Aug. 21, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Aravive Inc is a clinical-stage biopharmaceutical company. It focuses on developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis. The company pipeline product Batiraxcept (formerly AVB-500) which is an ultra-high affinity decoy protein that binds to GAS6 and thereby prevents AXL signaling to inhibit metastasis and tumor growth and restore sensitivity to anti-cancer agents. Batiraxcept is currently being evaluated in multiple clinical trials. |
| URL | https://www.aravive.com |
| Investor Relations URL | http://ir.versartis.com/ |
| HQ State/Province | Texas |
| Sector | |
| Industry | |
| Equity Style | Small Cap/Value |
| Next Earnings Release | Mar. 15, 2024 (est.) |
| Last Earnings Release | Aug. 21, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |